Novo NordiskNVO 
$134.852.11%24h
2.11%24h
Global rank13
Market cap$604.51B
Change 7d-2.33%
YTD Performance32.58%
SP500 benchmarkOutperform
P/E7.24
P/S17.47
Revenue$34.60B
Earnings$12.47B
Dividend yield0.8%
Main Sector
Healthcare
Category
Novo Nordisk (NVO) Cash on Hand
NVO Cash on Hand in 2022: $4.50B
According to Novo Nordisk latest financial reports the cash on hand of NVO is $4.50B, an increase of 28.23% to 2022. At the end of 2022 company had $3.51B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NVO Cash on Hand History from 2018 to 2023
-
Value:-
NVO Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $4.50B | 28.23% |
| 2022 | $3.51B | 34.82% |
| 2021 | $2.60B | 37.06% |
| 2020 | $1.90B | -17.56% |
| 2019 | $2.31B | -1.04% |
| 2018 | $2.33B | - |
View the Top Cash on Hand Companies 
